Severe Inhibition of Long-Chain Acyl-CoA Enoylhydratase (EC 4.2.1.74) in a Newborn Foal Suffering From Atypical Myopathy.
atypical myopathy
hypoglycin A (HGA)
long-chain enoyl-CoA hydratase (EC 4.2.1.74)
methylenecyclopropylglycine (MCPG)
newborn foal
vertical toxin transmission
Journal
Frontiers in veterinary science
ISSN: 2297-1769
Titre abrégé: Front Vet Sci
Pays: Switzerland
ID NLM: 101666658
Informations de publication
Date de publication:
2021
2021
Historique:
received:
27
08
2021
accepted:
27
09
2021
entrez:
12
11
2021
pubmed:
13
11
2021
medline:
13
11
2021
Statut:
epublish
Résumé
In horses, congenital defects of energy production from long-chain fatty acids have not been described so far. In contrast, inhibition of fatty acid degradation caused by the toxins hypoglycin A and methylenecyclopropylglycine from various maple species are observed frequently. These non-proteinogenic aminoacids are passed on placentally to fetuses or with collostrum or milk to newborn foals. Nevertheless, newborn foals become very rarely symptomatic. Vertical transmission apparently is not sufficient to induce clinical disease without a particular genetic constellation being present. One of these rare cases was investigated here using samples from a mare and her foal. Intoxication by hypoglycin A and methylenecyclopropylglycine is also of interest to human pathology, because these toxins have caused fatal poisonings after consumption of certain fruits many times, especially in children. Maple toxins, their metabolites and some short-chain acyl compounds were quantified by ultrahigh-pressure liquid chromatography/tandem mass spectrometry. An comprehensive spectrum of long-chain acylcarnitines was prepared using electrospray ionization tandem mass spectrometry. Organic acids and acylglycines were determined by gas chromatography mass spectrometry. For evaluation, results of other horses poisoned by maple material as well as unaffected control animals were used. In the serum of the foal, hypoglycin A was detected at a low concentration only. Toxin metabolites reached <3.5% of the mean of a comparison group of horses suffering from atypical myopathy. The spectrum of acylcarnitines indicated enzyme inhibition in short-chain and medium-chain regions typical of acer poisoning, but the measured concentrations did not exceed those previously found in clinically healthy animals after maple consumption. The values were not sufficient to explain the clinical symptoms. In contrast, a remarkably strong enrichment of tetradecenoylcarnitine and hexadecenoylcarnitine was observed. This proves a blockade of the long-chain enoyl-CoA hydratase (EC 4.2.1.74). Vertical transfer of maple toxins to a newborn foal is sufficient for induction of clinical disease only if there is an additional specific reactivity to the active toxins. This was found here in an inhibition of long-chain enoyl-CoA hydratase. Isolated dysfunction of this enzyme has not yet been reported in any species. Further studies are necessary to prove a specific genetic defect.
Identifiants
pubmed: 34765670
doi: 10.3389/fvets.2021.765623
pmc: PMC8576321
doi:
Types de publication
Journal Article
Langues
eng
Pagination
765623Informations de copyright
Copyright © 2021 Sander, Terhardt and Janzen.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Mol Genet Metab. 2008 Jan;93(1):30-5
pubmed: 17945527
Animals (Basel). 2020 Feb 24;10(2):
pubmed: 32102384
J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Sep 1;1029-1030:169-173
pubmed: 27433981
PLoS One. 2015 Sep 17;10(9):e0136785
pubmed: 26378918
Animals (Basel). 2021 Jan 05;11(1):
pubmed: 33466424
Semin Perinatol. 1999 Apr;23(2):183-93
pubmed: 10331469
J Vet Intern Med. 2018 Sep;32(5):1768-1772
pubmed: 30216546
J Vet Intern Med. 2021 Mar;35(2):1170-1176
pubmed: 33675130
Mol Genet Metab. 2005 Jun;85(2):108-14
pubmed: 15896654
Mol Genet Metab. 2011 Aug;103(4):341-8
pubmed: 21549624
J Vet Diagn Invest. 2016 Mar;28(2):98-104
pubmed: 26965229
J Agric Food Chem. 2017 Mar 29;65(12):2603-2608
pubmed: 28290200
Clin Chem. 2005 Mar;51(3):610-7
pubmed: 15615815
Clin Chem. 1989 Apr;35(4):587-95
pubmed: 2702744
Acta Paediatr Suppl. 1999 Dec;88(432):45-7
pubmed: 10626577
Toxicol Rep. 2019 Aug 05;6:803-808
pubmed: 31440457
Mol Genet Metab. 2007 Aug;91(4):362-9
pubmed: 17540595
J Vet Intern Med. 2021 Jan;35(1):606-609
pubmed: 33336854
Biochim Biophys Acta. 1976 Jan 23;422(1):8-14
pubmed: 1247597
Mol Genet Metab. 2020 Sep - Oct;131(1-2):23-37
pubmed: 33093005
Equine Vet J. 2016 Jul;48(4):414-7
pubmed: 26278545
G3 (Bethesda). 2018 May 4;8(5):1545-1554
pubmed: 29491033